APLS
Apellis Pharmaceuticals, Inc. · Healthcare · Biotechnology
Momentum-Eingaben (vergleichbare Manager):
Halterbreite +18.2% ·
Aktienfluss -4.3% ·
neue Nettopositionen +15.4%
— Formel
Eigentümerfragmentierung — mehr Halter, kleinere Gesamtbeteiligung
Alle Eigentumszahlen: nur beobachtete 13F-Manager, Stammaktienpositionen, Berichtszeitraum Q4 2024
| Quartal | Inhaber | Δ | Aktien | Gemeldeter Wert | Neu | Ausstiege |
|---|---|---|---|---|---|---|
| Q1 2026 | 99 | +3 | 79.10M | $3.12B | +14 | −12 |
| Q4 2025 | 97 | +1 | 73.39M | $1.84B | +2 | — |
| Q3 2025 | 19 | +1 | 50.24M | $1.14B | +1 | −1 |
| Q2 2025 | 16 | +2 | 43.69M | $756.24M | +2 | — |
| Q1 2025 | 11 | -2 | 24.93M | $545.30M | +1 | −3 |
| Q4 2024 | 13 | +2 | 23.82M | $760.24M | +3 | −1 |
| Q3 2024 | 10 | +2 | 20.37M | $587.46M | +2 | — |
| Q2 2024 | 8 | — | 21.17M | $811.69M | — | — |
| # | Manager | Aktien | Δ Anteile | Wert | Deren Gewichtung | Gehalten | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wellington Management ✦ | 11.80M | -24.2% | $376.57M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 2 | Wellington Management ✦ | 11.80M | -24.2% | $376.57M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 3 | Wellington Management ✦ | 11.80M | -24.2% | $376.57M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 4 | Wellington Management ✦ | 11.80M | -24.2% | $376.57M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 5 | Wellington Management ✦ | 11.80M | -24.2% | $376.57M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 6 | State Street Global Advisors ✦ (passiv) | 4.53M | — | $144.40M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | AQR Capital Management ✦ | 1.86M | +127.2% | $59.24M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 8 | AQR Capital Management ✦ | 1.86M | +127.2% | $59.24M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 9 | AQR Capital Management ✦ | 1.86M | +127.2% | $59.24M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 10 | AQR Capital Management ✦ | 1.86M | +127.2% | $59.24M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 11 | Geode Capital Management ✦ (passiv) | 1.84M | +1.6% | $58.70M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 12 | Geode Capital Management ✦ (passiv) | 1.84M | +1.6% | $58.70M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 13 | Point72 Asset Management ✦ | 1.27M | Neu | $40.46M | 0.1% | New | 1 | SEC ↗ |
| 14 | Norges Bank ✦ (passiv) | 1.09M | +1.7% | $34.66M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 15 | Millennium Management ✦ | 575.49K | +643.7% | $18.36M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 16 | T. Rowe Price ✦ | 358.58K | -5.2% | $11.44M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 17 | T. Rowe Price ✦ | 358.58K | -5.2% | $11.44M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 18 | Renaissance Technologies ✦ | 271.91K | -27.0% | $8.68M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 19 | Citadel Advisors ✦ | 112.42K | -43.3% | $3.59M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 20 | Marshall Wace ✦ | 85.50K | +292.4% | $2.73M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 21 | Marshall Wace ✦ | 85.50K | +292.4% | $2.73M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 22 | Marshall Wace ✦ | 85.50K | +292.4% | $2.73M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 23 | Gotham Asset Management ✦ | 24.30K | Neu | $775,381 | 0.0% | New | 1 | SEC ↗ |
| 24 | D. E. Shaw & Co. ✦ | 20.00K | Neu | $638,200 | 0.0% | New | 1 | SEC ↗ |
„Ihre Gewichtung" = Anteil der Position am gemeldeten 13F-Eigenkapitalwert des jeweiligen Managers — das Conviction-Maß. ✦ = kuratorisch ausgewählter Manager.
Neue Käufer
| Point72 Asset Management | $40.46M | 0.1% |
| Gotham Asset Management | $775,381 | 0.0% |
| D. E. Shaw & Co. | $638,200 | 0.0% |
Ausgestiegen
| Two Sigma Investments | $1.70M | war 0.0% |
Marktweiter Kontext: über ALLE 13F-Melder (strukturierte SEC-Daten, Q1 2026): 320 Inhaber, 137.95M Anteile, $5.43B gemeldet. Dies ist ein anderer, älterer Zeitraum als die oben genannten Zahlen des erfassten Universums; beide werden niemals vermischt.
Was die erfassten Halter dieses Wertpapiers am häufigsten sonst noch halten — Zählungen gemeinsamer Eigentümerschaft, keine fundamentalen Zusammenhänge.